Roche vet named Gilead CEO — and Genentech boss moves to Switzerland — in shuffle of top Bay Area biotech execs
December 10, 2018 at 04:13 AM EST
As Daniel O'Day takes the helm of Gilead, replacing longtime Chairman Bill Martin and CEO Bill Milligan, Roche will moves Genentech CEO into O'Day's old position and look for Genentech's fifth CEO in less than 10 years.